Pfizer (PFE) Potential Move Out of Country Seen as 'Dangerous': Carl Icahn
Get Alerts PFE Hot Sheet
Price: $25.08 -0.52%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.5%
Revenue Growth %: -1.8%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.5%
Revenue Growth %: -1.8%
Join SI Premium – FREE
Carl Icahn said Pfizer's (NYSE: PFE) potential move out of the country (rumor merger with AGN) is "much more dangerous than most people believe."
1/3 Unfortunately, my warning concerning the imminent exodus of many of our best companies is coming true.
— Carl Icahn (@Carl_C_Icahn) October 29, 2015
2/3 Today Pfizer confirmed they are planning to move out of the country. The situation is much more dangerous than most people believe.
— Carl Icahn (@Carl_C_Icahn) October 29, 2015
3/3 There is no reason Congress cannot act now to pass international tax reform with the Highway Bill.Read my letter https://t.co/fbbB8mNWMR
— Carl Icahn (@Carl_C_Icahn) October 29, 2015
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pfizer lung cancer drug misses survival goal in Phase 3 trial
- Orchid Island Capital expands buyback program, estimates book value rise
- ZenaTech raises Plurilock Security stake to 12% with new share purchase
Create E-mail Alert Related Categories
Hedge FundsRelated Entities
Carl Icahn, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share